Cas no 56843-28-8 (2,4-dichlorobenzaldehyde oxime)
2,4-dichlorobenzaldehyde oxime Chemical and Physical Properties
Names and Identifiers
-
- Benzaldehyde,2,4-dichloro-, oxime
- 2,4-DICHLOROBENZALDEHYDE OXIME
- 2,4-Dichlor-benzaldehyd-oxim
- 2,4-dichlorobenzadehyde oxime
- 2,4-dichloro-benzaldehyde-oxime
- 2,4-dichloro-benzaldehydoxime
- 2,4-dicholorobenzaldehydeoxime
- HONCHC6H3Cl2-2,4
- NCGC00323560-01
- AB01319032-02
- NSC75589
- HMS566E19
- (NE)-N-[(2,4-dichlorophenyl)methylidene]hydroxylamine
- CS-0356734
- MFCD00173694
- Benzaldehyde,4-dichloro-, oxime
- 56843-28-8
- NSC-75589
- Z49568347
- AKOS000304448
- NSC47499
- WLN: QNU1R BG DG
- 2,4-Dichorobenzaldehyde oxime
- (E)-2,4-dichlorobenzaldehyde oxime
- N-[(2,4-dichlorophenyl)methylidene]hydroxylamine
- Benzaldoxime,4-dichloro-
- EN300-15685
- CS-0235447
- NSC-47499
- 2,4-Dichlorobenzaldoxime
- 2,4-dichlorobenzaldehyde oxime
-
- Inchi: 1S/C7H5Cl2NO/c8-6-2-1-5(4-10-11)7(9)3-6/h1-4,11H/b10-4+
- InChI Key: ONJQBRVMFRQQIG-ONNFQVAWSA-N
- SMILES: ClC1C=C(C=CC=1/C=N/O)Cl
Computed Properties
- Exact Mass: 188.97500
- Monoisotopic Mass: 188.975
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 151
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 32.6A^2
- XLogP3: 2.9
Experimental Properties
- Density: 1.38
- Melting Point: 134℃
- Boiling Point: 271.3°Cat760mmHg
- Flash Point: 117.9°C
- Refractive Index: 1.575
- PSA: 32.59000
- LogP: 2.80150
2,4-dichlorobenzaldehyde oxime Security Information
- Safety Instruction: S26-S37/39
-
Hazardous Material Identification:
- Risk Phrases:R36/37/38
- Safety Term:S26;S37/39
2,4-dichlorobenzaldehyde oxime Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D439765-50mg |
2,4-dichlorobenzaldehyde oxime |
56843-28-8 | 50mg |
$ 50.00 | 2022-06-05 | ||
| TRC | D439765-100mg |
2,4-dichlorobenzaldehyde oxime |
56843-28-8 | 100mg |
$ 65.00 | 2022-06-05 | ||
| TRC | D439765-500mg |
2,4-dichlorobenzaldehyde oxime |
56843-28-8 | 500mg |
$ 135.00 | 2022-06-05 | ||
| Apollo Scientific | OR29744-1g |
2,4-Dichlorobenzaldoxime |
56843-28-8 | 1g |
£40.00 | 2025-02-19 | ||
| Enamine | EN300-6773378-50mg |
N-[(2,4-dichlorophenyl)methylidene]hydroxylamine |
56843-28-8 | 95.0% | 50mg |
$19.0 | 2023-09-24 | |
| Enamine | EN300-6773378-100mg |
N-[(2,4-dichlorophenyl)methylidene]hydroxylamine |
56843-28-8 | 95.0% | 100mg |
$19.0 | 2023-09-24 | |
| Enamine | EN300-6773378-250mg |
N-[(2,4-dichlorophenyl)methylidene]hydroxylamine |
56843-28-8 | 95.0% | 250mg |
$19.0 | 2023-09-24 | |
| Enamine | EN300-6773378-500mg |
N-[(2,4-dichlorophenyl)methylidene]hydroxylamine |
56843-28-8 | 95.0% | 500mg |
$21.0 | 2023-09-24 | |
| Enamine | EN300-6773378-1000mg |
N-[(2,4-dichlorophenyl)methylidene]hydroxylamine |
56843-28-8 | 95.0% | 1000mg |
$26.0 | 2023-09-24 | |
| Enamine | EN300-6773378-2500mg |
N-[(2,4-dichlorophenyl)methylidene]hydroxylamine |
56843-28-8 | 95.0% | 2500mg |
$32.0 | 2023-09-24 |
2,4-dichlorobenzaldehyde oxime Related Literature
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Jadwiga Frelek,Marcin Górecki,Marta ?aszcz,Agata Suszczyńska,Elemér Vass,Wojciech J. Szczepek Chem. Commun., 2012,48, 5295-5297
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
Additional information on 2,4-dichlorobenzaldehyde oxime
Introduction to 2,4-dichlorobenzaldehyde oxime (CAS No. 56843-28-8) in Modern Chemical Research
2,4-dichlorobenzaldehyde oxime, identified by the Chemical Abstracts Service registry number 56843-28-8, is a significant organic compound that has garnered considerable attention in the field of chemical biology and pharmaceutical development. This compound, featuring a benzaldehyde core substituted with two chlorine atoms at the 2- and 4-positions and an oxime functional group, exhibits unique chemical properties that make it a valuable intermediate in synthetic chemistry and a potential candidate for various biological applications.
The structure of 2,4-dichlorobenzaldehyde oxime contributes to its reactivity and utility. The presence of the aldehyde group (–CHO) allows for condensation reactions with various nucleophiles, while the oxime group (–NOH) introduces a polar moiety that can participate in hydrogen bonding interactions. These features are particularly relevant in the design of bioactive molecules, where specific interactions with biological targets are often critical for efficacy.
In recent years, the application of 2,4-dichlorobenzaldehyde oxime has been explored in several cutting-edge research areas. One notable area is its use as a precursor in the synthesis of heterocyclic compounds, which are widely employed in medicinal chemistry due to their diverse biological activities. The chlorine substituents on the benzene ring enhance electrophilic aromatic substitution reactions, facilitating the introduction of additional functional groups that can modulate biological activity.
Moreover, studies have highlighted the potential role of 2,4-dichlorobenzaldehyde oxime in the development of pharmaceutical agents. Researchers have leveraged its structural framework to design molecules with antimicrobial, anti-inflammatory, and anticancer properties. For instance, derivatives of this compound have been investigated for their ability to interact with specific enzymes or receptors involved in disease pathways. The oxime group, in particular, has been shown to form stable complexes with metal ions, which can be exploited in therapeutic applications such as metallodrug development.
The synthesis of 2,4-dichlorobenzaldehyde oxime typically involves the reaction of 2,4-dichlorobenzaldehyde with hydroxylamine hydrochloride under controlled conditions. This reaction proceeds via nucleophilic addition followed by tautomerization to yield the desired oxime derivative. Advances in synthetic methodologies have improved the efficiency and scalability of this process, making it more accessible for industrial applications.
Recent advancements in computational chemistry have also contributed to a deeper understanding of the properties and reactivity of 2,4-dichlorobenzaldehyde oxime. Molecular modeling studies have revealed insights into its binding interactions with biological targets, providing a rational basis for structure-activity relationship (SAR) studies. These computational approaches complement experimental work by predicting potential lead compounds and optimizing their designs before synthesis.
In addition to its pharmaceutical relevance, 2,4-dichlorobenzaldehyde oxime has found applications in material science. Its ability to form coordination complexes with transition metals makes it useful in catalysis and as a ligand for metal-organic frameworks (MOFs). These materials have potential uses in gas storage, separation technologies, and as sensors for environmental monitoring.
The biological activity of 2,4-dichlorobenzaldehyde oxime has been further explored through in vitro and in vivo studies. Research indicates that certain derivatives exhibit inhibitory effects on enzymes such as cytochrome P450 monooxygenases, which play crucial roles in drug metabolism. By modulating these enzymatic pathways, compounds derived from this scaffold may offer therapeutic advantages in drug development.
Future research directions may focus on expanding the synthetic toolbox for 2,4-dichlorobenzaldehyde oxime, enabling the preparation of more complex derivatives with tailored properties. Additionally, investigating its role in green chemistry could lead to more sustainable synthetic routes that minimize waste and energy consumption.
Overall,2,4-dichlorobenzaldehyde oxime (CAS No. 56843-28-8) represents a versatile compound with broad applications across multiple scientific disciplines. Its unique structural features and reactivity make it a valuable building block for innovative chemical synthesis and a promising candidate for future pharmaceutical discoveries.
56843-28-8 (2,4-dichlorobenzaldehyde oxime) Related Products
- 3717-28-0(2-Chlorobenzaldehyde oxime)
- 3717-26-8(Benzaldehyde,2-chloro-, oxime, [C(E)]-)
- 3848-36-0(4-Chlorobenzaldehyde Oxime)
- 5331-92-0(3,4-dichlorobenzaldehyde oxime)
- 25185-95-9(2,6-Dichlorobenzaldehyde oxime)
- 4414-54-4(2,3-Dichlorobenzaldoxime)
- 92062-57-2(3-chlorobenzaldehyde oxime)
- 3717-24-6(Benzaldehyde,4-chloro-, oxime, [C(E)]-)
- 29450-63-3(Benzaldehyde,2,3,4,5,6-pentachloro-, oxime)
- 71516-67-1(2,4-Dichloroacetophenone Oxime)